A substantial real-world study has underlined the efficacy of both adjuvanted and high-dose influenza vaccines in individuals aged 65 and above. The research involved more than 430,000 adults from 65 different healthcare facilities, essentially reinforcing the current Advisory Committee on Immunization Practices (ACIP) guidelines nuancing that both vaccines are suitable options for this demographic at…
Over the past year, it's become apparent that there's a disconnection between progressive scientific research and the interpretation of public health information by the common public. This gap, which has been amplified by the COVID-19 pandemic, has sparked confusion and misunderstanding about crucial health guidelines and has yielded fertile ground for misinformation by vaccine skeptics…